Surprisingly, according to researchers,, control of type 1 and 2 diabetes "was not significantly improved by free distribution."
It seems like a no-brainer: removing the cost barrier to a prescription drug will improve patient adherence. But, according to a team of Canadian researchers, free drugs won't convince all patients to swallow those pills.
As reported in a recent JAMA article, offering to remove cost barriers to life-saving prescription drugs does encourage adherence. The researchers identified more than 700 Canadian patients who said they had stopped taking their drugs as prescribed due to the cost to them. The team divided the groups into two, one receiving their drugs for free, the other continuing to access their drugs as they had previously. After one year, they checked in with the groups to review adherence to the 128 drugs on the list.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Dan Cook
Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.
